A powerful directive has been issued in New York, demanding a major hospital system reinstate vital healthcare services for transgender youth. Attorney General Letitia James is compelling NYU Langone to reverse its recent decision to halt gender-transition treatments, a move she argues directly violates state anti-discrimination laws.
The hospital abruptly ended its Transgender Youth Health Program last month, citing concerns over potential funding cuts stemming from a Trump administration initiative. James’ office contends this action wasn’t simply a business decision, but a dangerous disruption of medically necessary care for a particularly vulnerable population.
The Attorney General’s letter, delivered February 25th, doesn’t mince words. It asserts the program’s closure “jeopardized access to healthcare” and threatens “further action” if hormone therapies, puberty blockers, and other essential treatments aren’t immediately resumed for young patients.
NYU Langone initially explained the closure as a consequence of a departing medical director and a shifting “regulatory environment.” They emphasized a commitment to assisting existing patients through the transition, while maintaining pediatric mental health services.
The roots of this conflict trace back to an executive order issued by former President Donald Trump, framed as “Protecting Children from Chemical and Surgical Mutilation.” This order aimed to restrict gender-affirming care for those under 19, sparking widespread concern within the medical community.
Following the order, the U.S. Department of Health and Human Services proposed cutting federal funding – Medicaid and Medicare – from hospitals offering these treatments. This created a chilling effect, prompting several institutions nationwide to reconsider their programs.
However, the Attorney General’s office argues the proposed funding cuts never translated into actual changes in federal law. Darsana Srinivasan, chief of the health care bureau, emphasized that NYU Langone’s existing legal obligations under New York state law remained unchanged.
The letter underscores the potentially devastating consequences of denying transgender youth access to crucial medical care. Srinivasan warned that the sudden discontinuation of treatment could lead to “severe, negative health outcomes” for this vulnerable group.
NYU Langone has been given until March 11th to demonstrate compliance. The specific repercussions for failing to reinstate the program remain unclear, but the Attorney General’s firm stance signals a willingness to vigorously defend the rights of transgender youth in New York.
This case isn’t isolated. Numerous hospitals across the country have faced similar pressures, highlighting a broader national struggle over access to gender-affirming care and the rights of transgender individuals.
